Home › Neurofibrosarcoma › New York
Pag-aaral pangklinika para sa Neurofibrosarcoma sa New York
6 pag-aaral para sa Neurofibrosarcoma ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
- New york cancer and blood specialists - Oncology, Port Jefferson Station
- at 1 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT05245500SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- at 1 pa
Nagre-recruitPhase 2
12 Months · Lahat ng kasarian · Na-update May 6, 2026 · NCT05985161Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Mar 9, 2026 · NCT03141021A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- at 1 pa
Nagre-recruitPhase 2
Edad 16 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT04872543Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.